Golden Throat (06896) published its latest monthly return on movements in securities for the period ended 28 February 2026. The authorized share capital remained at 2.00 billion ordinary shares, each with a par value of USD 0.000025, totaling USD 50,000. The number of issued shares also remained unchanged at 739.30 million, with a public float confirming compliance with the 25% regulatory requirement.

No additional issuance or movement was recorded under the company’s share option scheme; 73.93 million shares remain available for potential future issuance. No treasury shares were held, repurchased, or cancelled. All relevant details were confirmed by the Non-executive Director and Chairman of the Board of Directors, reflecting no significant changes in share capital during the reporting month.